Small intestinal sampling capsule for inflammatory bowel disease type detection and management-Reference-Cited by-同舟云学术

Small intestinal sampling capsule for inflammatory bowel disease type detection and management

Published:2022 Issue:1 Volume:22 Page:57-70
ISSN:1473-0197
Container-title:Lab on a Chip
language:en
Short-container-title:Lab Chip

Author:

Nejati Sina¹²^ORCID,Wang Jiangshan²³,Heredia-Rivera Ulisses¹²,Sedaghat Sotoudeh¹²^ORCID,Woodhouse Ian¹²,Johnson Jay S.⁴,Verma Mohit²³⁵^ORCID,Rahimi Rahim¹²^ORCID

Affiliation:

1. School of Materials Engineering, Purdue University, West Lafayette, IN, 47907, USA

2. Birck Nanotechnology Center, Purdue University, West Lafayette, IN, 47907, USA

3. Department of Agricultural and Biological Engineering, Purdue University, West Lafayette, IN 47907, USA

4. USDA-ARS Livestock Behavior Research Unit, West Lafayette, IN 47907, USA

5. Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN 47907, USA

Abstract

A non-invasive sampling capsule is introduced to site-selectively collect calprotectin biomarker from the small intestine. This approach can be accompanied with the fecal calprotectin assay to diagnose IBD and differentiate its types (CD and UC).

Funder

Eli Lilly and Company

Publisher

Royal Society of Chemistry (RSC)

Subject

Biomedical Engineering,General Chemistry,Biochemistry,Bioengineering

Link

http://pubs.rsc.org/en/content/articlepdf/2022/LC/D1LC00451D

Reference58 articles.

1. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group

3. An Update on Inflammatory Bowel Disease